Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference
31 7월 2019 - 7:00PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in
point-of-care diagnostic tests and specimen collection devices,
today announced that Dr. Stephen S. Tang, President and CEO, will
speak to the investment community at the 39th Annual Canaccord
Genuity Growth Conference. The conference will be
simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on Wednesday,
August 7, 2019, at approximately 8:00 AM Eastern Time (5:00 AM
Pacific Time). Interested investors can access the live
webcast of the presentation by going to OraSure Technologies’ web
site, www.orasure.com and clicking on the Investors link. A
replay of the webcast will be available on OraSure Technologies’
web site for seven days. Alternatively, you can access the
live webcast of the presentation via the following link:
http://wsw.com/webcast/canaccord35/osur/
About OraSure
Technologies
OraSure Technologies is empowering the global
community to improve health and wellness by providing access to
accurate essential information. OraSure is a leader in the
development, manufacture and distribution of point-of-care
diagnostic tests, molecular collection devices and other
technologies designed to detect or diagnose critical medical
conditions. Its first-to-market, innovative products include rapid
tests for the detection of antibodies to HIV and Hepatitis C (HCV)
on the OraQuick® platform, sample self-collection and stabilization
products for molecular applications, and oral fluid laboratory
tests for detecting various drugs of abuse. Together with its
wholly-owned subsidiaries (DNA Genotek, CoreBiome and Novosanis),
OraSure provides its customers with value-added, end-to-end
solutions that encompass tools, diagnostics and services. OraSure’s
portfolio of products is sold globally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research institutions,
distributors, government agencies, physicians’ offices, commercial
and industrial entities and consumers. For more information on
OraSure Technologies, please visit www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial Officer |
VP Corporate Communications |
610-882-1820 |
484-353-1575 |
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024